Document:

Registration Rights Agreement for the 7 1/4% Senior Subordinated Notes due 2015

 EXHIBIT 10.2 
 EXECUTION VERSION 
  
 REGISTRATION RIGHTS AGREEMENT 
  
 This REGISTRATION RIGHTS AGREEMENT dated March 22, 2005 (the “Agreement”) is entered into by and among DaVita Inc., a Delaware corporation (the “Company”), the guarantors listed in
Schedule 1 hereto (the “Guarantors”), and J.P. Morgan Securities Inc. (“JPMorgan”), on behalf of itself and on behalf of the several Initial Purchasers identified on Schedule 1 to the Purchase Agreement (the
“Initial Purchasers”). 
  
 The Company, the
Guarantors and the Initial Purchasers are parties to the Purchase Agreement dated March 15, 2005 (the “Purchase Agreement”), which provides for, among other things, the sale by the Company to the Initial Purchasers of $850,000,000
aggregate principal amount of the Company’s 7 1/4% Senior Subordinated Notes due 2015 (the “Securities”) which will be guaranteed on an unsecured senior subordinated basis by each of the Guarantors. As an inducement to the
Initial Purchasers to enter into the Purchase Agreement, the Company and the Guarantors have agreed to provide to the Initial Purchasers and their direct and indirect transferees the registration rights set forth in this Agreement. The execution and
delivery of this Agreement is a condition to the closing under the Purchase Agreement. 
  
 In consideration of the foregoing, the parties hereto agree as follows: 
  
 1. Definitions. As used in this Agreement, the following terms shall have the following meanings: 
  
 “Business Day” shall mean any day that is not a Saturday,
Sunday or other day on which commercial banks in New York City are authorized or required by law to remain closed. 
  
 “Closing Date” shall mean the Closing Date as defined in the Purchase Agreement. 
  
 “Company” shall have the meaning set forth in the preamble
and shall also include the Company’s successors. 
  
 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended from time to time. 
  
 “Exchange Dates” shall have the meaning set forth in Section 2(a)(ii) hereof. 
  
 “Exchange Offer” shall mean the exchange offer by the
Company and the Guarantors of Exchange Securities for Registrable Securities pursuant to Section 2(a) hereof. 
  
 “Exchange Offer Registration” shall mean a registration under the Securities Act effected pursuant to Section 2(a) hereof. 
  
 “Exchange Offer Registration Statement” shall mean an
exchange offer registration statement on Form S-4 (or, if applicable, on another appropriate form) and all amendments and supplements to such registration statement, in each case including the Prospectus contained therein, all exhibits thereto and
any document incorporated by reference therein. 
  
 “Exchange Securities” shall mean senior subordinated notes issued by the Company and guaranteed by the Guarantors under the Indenture containing terms identical to the Securities (except that the Exchange Securities will
not be subject to restrictions on transfer or to any increase in annual interest rate 

  

 
for failure to comply with this Agreement) and to be offered to Holders of Securities in exchange for Securities pursuant to the Exchange Offer. 

 
 “Guarantors” shall have the meaning set forth in the
preamble and shall also include any Guarantor’s successors. 
  
 “Holders” shall mean the Initial Purchasers, for so long as they own any Registrable Securities, and each of their successors, assigns and direct and indirect transferees who become owners of Registrable Securities under
the Indenture; provided that for purposes of Sections 4 and 5 of this Agreement, the term “Holders” shall include Participating Broker-Dealers. 
  

“Indenture” shall mean the Indenture relating to the Securities dated as of the Closing Date among the Company, the Guarantors and The
Bank of New York Trust Company, N.A., as trustee, and as the same may be amended from time to time in accordance with the terms thereof. 
  
 “Initial Purchasers” shall have the meaning set forth in the preamble. 
  
 “Inspector” shall have the meaning set forth in Section 3(a)(xiii) hereof. 
  
 “JPMorgan” shall have the meaning set forth in the preamble.

  
 “Majority Holders” shall mean the Holders of
a majority of the aggregate principal amount of the outstanding Registrable Securities; provided that whenever the consent or approval of Holders of a specified percentage of Registrable Securities is required hereunder, any Registrable
Securities owned directly or indirectly by the Company or any of its affiliates (as such term is defined in Rule 405 under the Securities Act) shall not be counted in determining whether such consent or approval was given by the Holders of such
required percentage or amount; and provided, further, that if the Company shall issue any additional Securities under the Indenture prior to consummation of the Exchange Offer or, if applicable, the effectiveness of any Shelf
Registration Statement, such additional Securities and the Registrable Securities to which this Agreement relates shall be treated together as one class for purposes of determining whether the consent or approval of Holders of a specified percentage
of Registrable Securities has been obtained. 
  
 “Participating Broker-Dealers” shall have the meaning set forth in Section 4(a) hereof. 
  
 “Person” shall mean an individual, partnership, limited liability company, corporation, trust or unincorporated organization, or a
government or agency or political subdivision thereof. 
  
 “Prospectus” shall mean the prospectus included in a Registration Statement, including any preliminary prospectus, and any such prospectus as amended or supplemented by any prospectus supplement, including a prospectus
supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by a Shelf Registration Statement, and by all other amendments and supplements to such prospectus, and in each case including any document
incorporated by reference therein. 
  
 “Purchase
Agreement” shall have the meaning set forth in the preamble. 
  
 “Registrable Securities” shall mean the Securities; provided that the Securities shall cease to be Registrable Securities (i) when a Registration Statement with respect to such Securities has been declared effective
under the Securities Act and such Securities have been exchanged or disposed of pursuant to such Registration Statement, (ii) when such Securities are eligible to be sold pursuant to Rule 144(k) (or 

  

 -2- 

 
any similar provision then in force, but not Rule 144A) under the Securities Act or (iii) when such Securities cease to be outstanding. 
  
 “Registration Expenses” shall mean any and all expenses
incident to performance of or compliance by the Company and the Guarantors with this Agreement, including without limitation: (i) all SEC, stock exchange or National Association of Securities Dealers, Inc. registration and filing fees, (ii) all fees
and expenses incurred in connection with compliance with state securities or blue sky laws (including reasonable fees and disbursements of counsel for any Underwriters or Holders in connection with blue sky qualification of any Exchange Securities
or Registrable Securities), (iii) all out-of-pocket expenses of any Persons in preparing or assisting in preparing, word processing, printing and distributing any Registration Statement, any Prospectus and any amendments or supplements thereto, any
underwriting agreements, securities sales agreements or other similar agreements and any other documents relating to the performance of and compliance with this Agreement, (iv) all rating agency fees, (v) all fees and disbursements relating to the
qualification of the Indenture under applicable securities laws, (vi) the fees and disbursements of the Trustee and its counsel, (vii) the fees and disbursements of counsel for the Company and the Guarantors and, in the case of a Shelf Registration
Statement, the fees and disbursements of one counsel for the Holders (which counsel shall be selected by the Majority Holders and which counsel may also be counsel for the Initial Purchasers) and (viii) the fees and disbursements of the independent
public accountants of the Company and the Guarantors, including the expenses of any special audits or “comfort” letters required by or incident to the performance of and compliance with this Agreement, but excluding fees and expenses of
counsel to the Underwriters (other than fees and expenses set forth in clause (ii) above) or the Holders and underwriting discounts and commissions, brokerage commissions and transfer taxes, if any, relating to the sale or disposition of Registrable
Securities by a Holder. 
  
 “Registration
Statement” shall mean any registration statement of the Company and the Guarantors that covers any of the Exchange Securities or Registrable Securities pursuant to the provisions of this Agreement and all amendments and supplements to any
such registration statement, including post-effective amendments, in each case including the Prospectus contained therein, all exhibits thereto and any document incorporated by reference therein. 
  
 “SEC” shall mean the United States Securities and Exchange
Commission. 
  
 “Securities Act” shall mean the
Securities Act of 1933, as amended from time to time. 
  
 “Senior Registration Rights Agreement” shall have the meaning set forth in the Indenture. 
  
 “Shelf Effectiveness Period” shall have the meaning set forth in Section 2(b) hereof. 
  
 “Shelf Registration” shall mean a registration effected
pursuant to Section 2(b) hereof. 
  
 “Shelf Registration
Statement” shall mean a “shelf” registration statement of the Company and the Guarantors that covers all or a portion of the Registrable Securities (but no other securities (other than Registrable Securities as such term is
defined Senior Registration Rights Agreement) unless approved by the Holders whose Registrable Securities are to be covered by such Shelf Registration Statement) on an appropriate form under Rule 415 under the Securities Act, or any similar rule
that may be adopted by the SEC, and all amendments and supplements to such registration statement, including post-effective amendments, in each case including the Prospectus contained therein, all exhibits thereto and any document incorporated by
reference therein. 
  
 “Staff” shall mean the
staff of the SEC. 
  

 -3- 

 “Target Date” shall have the meaning set forth in Section 2(d) hereof. 
  
 “Trust Indenture Act” shall mean the Trust Indenture Act of
1939, as amended from time to time. 
  
 “Trustee”
shall mean the trustee with respect to the Securities under the Indenture. 
  
 “Underwriter” shall have the meaning set forth in Section 3(e) hereof. 
  
 “Underwritten Offering” shall mean an offering in which Registrable Securities are sold to an Underwriter for reoffering to the public.

  
 2. Registration Under the Securities Act. 

 
 (a) To the extent not prohibited by any applicable law or applicable
interpretations of the Staff, the Company and the Guarantors shall (i) within 270 days of the Closing Date, cause to be filed an Exchange Offer Registration Statement covering an offer to the Holders to exchange all the Registrable Securities for
Exchange Securities and (ii) use their reasonable best efforts to (x) cause such Registration Statement to become and be declared effective within 360 days of the Closing Date and (y) cause such Exchange Offer Registration Statement to remain
effective until the earlier of (A) 180 days after the closing of the Exchange Offer and (B) the first day after the consummation of the Exchange Offer when Participating Broker-Dealers no longer have a prospectus delivery obligation under Staff
interpretations. The Company and the Guarantors shall commence the Exchange Offer promptly after the Exchange Offer Registration Statement is declared effective by the SEC and use their reasonable best efforts to complete the Exchange Offer not
later than 45 days after such effective date. 
  
 The Company and
the Guarantors shall commence the Exchange Offer by mailing the related Prospectus, appropriate letters of transmittal and other accompanying documents to each Holder stating, in addition to such other disclosures as are required by applicable law,
substantially the following: 
  
 (i) that the
Exchange Offer is being made pursuant to this Agreement and that all Registrable Securities validly tendered and not properly withdrawn will be accepted for exchange; 
  
 (ii) the dates of acceptance for exchange (which shall be a period of at least 20 Business Days from the
date such notice is mailed) (the “Exchange Dates”); 
  
 (iii) that any Registrable Security not tendered will remain outstanding and continue to accrue interest but will not retain any rights under this Agreement; 
  
 (iv) that any Holder electing to have a Registrable Security
exchanged pursuant to the Exchange Offer will be required to surrender such Registrable Security, together with the appropriate letters of transmittal, to the institution and at the address (located in the Borough of Manhattan, The City of New York)
and in the manner specified in the notice, prior to the close of business on the last Exchange Date; and 
  
 (v) that any Holder will be entitled to withdraw its election, not later than the close of business, New York City time, on the last
Exchange Date that is a Business Day, by sending to the institution and at the address (located in the Borough of Manhattan, The City of New York) specified in the notice, a telegram, telex, facsimile transmission or letter setting forth the name of

  

 -4- 

 
such Holder, the principal amount of Registrable Securities delivered for exchange and a statement that such Holder is withdrawing its election to have such
Securities exchanged. 
  
 As a condition to participating in the
Exchange Offer, a Holder will be required to represent to the Company and the Guarantors that (i) any Exchange Securities to be received by it will be acquired in the ordinary course of its business, (ii) at the time of the commencement of the
Exchange Offer it has no arrangement or understanding with any Person to participate in the distribution (within the meaning of the Securities Act) of the Exchange Securities in violation of the provisions of the Securities Act, (iii) it is not an
“affiliate” (within the meaning of Rule 405 under the Securities Act) of the Company or any Guarantor, (iv) it is not engaged in, and does not intend to engage in, the distribution (within the meaning of the Securities Act) of the Exchange
Securities, (v) if such Holder is a broker-dealer, it did not purchase the notes being tendered in the Exchange Offer directly from the Company for resale pursuant to Rule 144A under the Securities Act or any other available exemption from
registration under the Securities Act, and (vi) if such Holder is a broker-dealer that will receive Exchange Securities for its own account in exchange for Registrable Securities that were acquired as a result of market-making or other trading
activities, then such Holder will deliver a Prospectus in connection with any resale of such Exchange Securities. 
  
 As soon as practicable after the last Exchange Date, the Company and the Guarantors shall: 
  
 (i) accept for exchange Registrable Securities or portions thereof validly tendered and not properly
withdrawn pursuant to the Exchange Offer; and 
  
 (ii) deliver, or cause to be delivered, to the Trustee for cancellation all Registrable Securities or portions thereof so accepted for exchange by the Company and issue, and cause the Trustee to promptly authenticate and deliver to each
Holder, Exchange Securities equal in principal amount to the principal amount of the Registrable Securities surrendered by such Holder. 
  
 The Company and the Guarantors shall use their reasonable best efforts to complete the Exchange Offer as provided above and shall comply with the
applicable requirements of the Securities Act, the Exchange Act and other applicable laws and regulations in connection with the Exchange Offer. The Exchange Offer shall not be subject to any conditions, other than (i) that the Exchange Offer does
not violate any applicable law or applicable interpretations of the Staff and (ii) that no action or proceeding shall have been instituted in any court or by or before any governmental agency with respect to the Exchange Offer which, in the
Company’s judgment, would reasonably be expected to prevent the Company and the Guarantors from proceeding with or completing the Exchange Offer. 
  
 (b) In the event that (i) the Company and the Guarantors determine that the Exchange Offer Registration provided for in Section 2(a) above is not
available or may not be completed as soon as practicable after the last Exchange Date because it would violate any applicable law or applicable interpretations of the Staff, (ii) the Exchange Offer is not for any other reason completed by the date
that is 395 days from the Closing Date or (iii) any Initial Purchaser shall so request in writing not later than 90 Business Days following completion of the Exchange Offer with respect to the Registrable Securities not eligible to be exchanged for
Exchange Securities in the Exchange Offer and held by it, the Company and the Guarantors shall use their reasonable best efforts to cause to be filed as soon as practicable after such determination, date or request, as the case may be, a Shelf
Registration Statement providing for the sale of all the Registrable Securities by the Holders thereof and to have such Shelf Registration Statement declared effective by the SEC. 
  
 In the event that the Company and the Guarantors are required to file a Shelf Registration Statement pursuant to clause
(iii) of the preceding sentence, the Company and the Guarantors shall use their 

  

 -5- 

 
reasonable best efforts to file and have declared effective by the SEC both an Exchange Offer Registration Statement pursuant to Section 2(a) with respect to
all Registrable Securities and a Shelf Registration Statement (which may be a combined Registration Statement with the Exchange Offer Registration Statement) with respect to offers and sales of Registrable Securities held by the Initial Purchasers
after completion of the Exchange Offer. 
  
 The Company and the
Guarantors agree to use their reasonable best efforts to keep the Shelf Registration Statement continuously effective until the expiration of the period referred to in Rule 144(k) (or any similar rule then in force, but not Rule 144A) under the
Securities Act with respect to the Registrable Securities or such shorter period that will terminate when all the Registrable Securities covered by the Shelf Registration Statement have been sold pursuant to the Shelf Registration Statement or
otherwise cease to be Registrable Securities (the “Shelf Effectiveness Period”). The Company and the Guarantors further agree to supplement or amend the Shelf Registration Statement and the related Prospectus if required by the
rules, regulations or instructions applicable to the registration form used by the Company for such Shelf Registration Statement or by the Securities Act or by any other rules and regulations thereunder for shelf registration or if reasonably
requested by a Holder of Registrable Securities with respect to information relating to such Holder, and to use their reasonable best efforts to cause any such amendment to become effective and such Shelf Registration Statement and Prospectus to
become usable as soon as thereafter practicable. The Company and the Guarantors agree to furnish to the Holders of Registrable Securities copies of any such supplement or amendment promptly after its being used or filed with the SEC. 
  
 (c) The Company and the Guarantors shall pay all Registration Expenses in
connection with any registration pursuant to Section 2(a) or Section 2(b) hereof. Each Holder shall pay all underwriting discounts and commissions, brokerage commissions and transfer taxes, if any, relating to the sale or disposition of such
Holder’s Registrable Securities pursuant to the Shelf Registration Statement. 
  
 (d) An Exchange Offer Registration Statement pursuant to Section 2(a) hereof or a Shelf Registration Statement pursuant to Section 2(b) hereof will not be deemed to have become effective unless it has been declared
effective by the SEC. 
  
 In the event that either the Exchange
Offer is not completed or the Shelf Registration Statement, if required hereby, is not declared effective by 5:00 p.m. (Eastern Standard Time) on the date that is 395 days after the Closing Date (the “Target Date”), the interest
rate on the Registrable Securities will be increased by (i) 0.25% per annum for the first 90-day period following the Target Date and (ii) an additional 0.25% per annum with respect to each subsequent 90-day period, in each case until the Exchange
Offer is completed or the Shelf Registration Statement, if required hereby, is declared effective by the SEC or the Securities become freely tradable under the Securities Act, up to a maximum of 1.00% per annum of additional interest. 
  
 If the Shelf Registration Statement, if required hereby, has been declared
effective and thereafter at any time after the Target Date either ceases to be effective or the Prospectus contained therein ceases to be usable at any time during the Shelf Effectiveness Period, and such failure to remain effective or usable exists
for more than 45 days (whether or not consecutive) in any 12-month period, then the interest rate on the Registrable Securities with respect to any period during which the Shelf Registration Statement ceases to be effective or the Prospectus
contained therein ceases to be usable will be increased by (i) 0.25% per annum for the first 90-day period immediately commencing on the 46th day in such 12-month period and (ii) an additional 0.25% per annum with respect to each subsequent 90-day
period, in each case until the Shelf Registration Statement has again been declared effective or the Prospectus again becomes usable, up to a maximum of 1.00% per annum of additional interest. 
  

 -6- 

 (e) Without limiting the remedies available to the Initial Purchasers and the Holders, the Company and
the Guarantors acknowledge that any failure by the Company or the Guarantors to comply with their obligations under Section 2(a) and Section 2(b) hereof may result in material irreparable injury to the Initial Purchasers or the Holders for which
there is no adequate remedy at law, that it will not be possible to measure damages for such injuries precisely and that, in the event of any such failure, the Initial Purchasers or any Holder may obtain such relief as may be required to
specifically enforce the Company’s and the Guarantors’ obligations under Section 2(a) and Section 2(b) hereof. 
  
 3. Registration Procedures. 
  
 (a) In connection with their obligations pursuant to Section 2(a) and Section 2(b) hereof, the Company and the Guarantors shall: 
  
 (i) prepare and file with the SEC a Registration Statement,
within the time periods specified by Section 2 hereof, on the appropriate form under the Securities Act, which form (x) shall be selected by the Company and the Guarantors, (y) shall, in the case of a Shelf Registration, be available for the sale of
the Registrable Securities by the Holders thereof and (z) shall comply as to form in all material respects with the requirements of the applicable form and include all financial statements required by the SEC to be filed therewith; and use their
reasonable best efforts to cause such Registration Statement to become effective and remain effective for the applicable period in accordance with Section 2 hereof; 
  
 (ii) use their reasonable best efforts to prepare and file with the SEC such amendments and post-effective
amendments to each Registration Statement as may be necessary under applicable law to keep such Registration Statement effective for the applicable period in accordance with Section 2 hereof and cause each Prospectus to be supplemented by any
required prospectus supplement and, as so supplemented, to be filed pursuant to Rule 424 under the Securities Act; and keep each Prospectus current during the period described in Section 4(3) of and Rule 174 under the Securities Act that is
applicable to transactions by brokers or dealers with respect to the Registrable Securities or Exchange Securities; 
  
 (iii) in the case of a Shelf Registration, furnish to each Holder of Registrable Securities, to counsel for the Initial Purchasers, to
counsel for such Holders and to each Underwriter of an Underwritten Offering of Registrable Securities, if any, without charge, as many copies of each Prospectus, including each preliminary Prospectus, and any amendment or supplement thereto as such
Holder, counsel or Underwriter may reasonably request, in order to facilitate the sale or other disposition of the Registrable Securities thereunder; and subject to Section 3(d) hereof, the Company and the Guarantors consent to the use of such
Prospectus and any amendment or supplement thereto in accordance with applicable law by each of the Holders of Registrable Securities and any such Underwriters in connection with the offering and sale of the Registrable Securities covered by and in
the manner described in such Prospectus or any amendment or supplement thereto in accordance with applicable law; 
  
 (iv) use their reasonable best efforts to register or qualify the Registrable Securities under all applicable state securities or blue sky
laws of such jurisdictions within the United States as any Holder of Registrable Securities covered by a Registration Statement shall reasonably request in writing by the time the applicable Registration Statement is declared effective by the SEC;
cooperate with such Holders in connection with any filings required to be made with the National Association of Securities Dealers, Inc.; and do any and all other acts and things that may be reasonably necessary or advisable to enable each Holder to
complete the disposition in each such jurisdiction of the Registrable Securities owned by such Holder; provided that neither the 

  

 -7- 

 
Company nor any Guarantor shall be required to (1) qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction
where it would not otherwise be required to so qualify, (2) file any general consent to service of process in any such jurisdiction or (3) subject itself to taxation in any such jurisdiction if it is not so subject; 
  
 (v) in the case of a Shelf Registration, notify each Holder
of Registrable Securities, counsel for such Holders and counsel for the Initial Purchasers promptly and, if requested by any such Holder or counsel, confirm such advice in writing (1) when a Registration Statement has become effective and when any
post-effective amendment thereto has been filed and becomes effective, (2) of any request by the SEC or any state securities authority for amendments and supplements to a Registration Statement and Prospectus or for additional information after the
Registration Statement has become effective, (3) of the issuance by the SEC or any state securities authority of any stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose, (4) if,
between the effective date of a Registration Statement and the closing of any sale of Registrable Securities covered thereby, the representations and warranties of the Company or any Guarantor contained in any underwriting agreement, securities
sales agreement or other similar agreement, if any, relating to an offering of such Registrable Securities cease to be true and correct in all material respects or if the Company or any Guarantor receives any notification with respect to the
suspension of the qualification of the Registrable Securities for sale in any jurisdiction or the initiation of any proceeding for such purpose, (5) of the happening of any event during the period a Shelf Registration Statement is effective that
requires the making of any changes in such Registration Statement or Prospectus in order that the Registration Statement or Prospectus not contain an untrue statement of a material fact nor omit to state a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, (6) of any determination by the Company or any Guarantor that a post-effective amendment to a Registration Statement would be
appropriate (other than a post-effective amendment the sole purpose of which is to add additional selling securityholders) and (7) of any determination by the Company (other than for the avoidance of its obligations under this Agreement), in the
exercise of its reasonable judgment, that (A) it is not in the best interests of the Company and its stockholders to disclose a possible acquisition or business combination or other transaction, business development or event involving the Company
that may require disclosure in the Shelf Registration Statement, or if required to be kept effective after consummation of the Exchange Offer, the Exchange Offer Registration Statement, or (B) obtaining any financial statements relating to an
acquisition or business combination required to be included in the Shelf Registration Statement, or if required to be kept effective after consummation of the Exchange Offer, the Exchange Offer Registration Statement, would be impracticable. Any
notice provided pursuant to this Section 3(a)(v)(7) shall not be required to disclose any such possible acquisition, business combination or other transaction, business development or event if the Company determines in the exercise of its reasonable
judgment that such acquisition or business combination or other transaction, business development or event should remain confidential. 
  
 (vi) use their reasonable best efforts to obtain the withdrawal of any order suspending the effectiveness of a Registration Statement at
the earliest possible moment and provide prompt notice to each Holder of the withdrawal of any such order; 
  
 (vii) in the case of a Shelf Registration, furnish to each Holder of Registrable Securities included in such Shelf Registration, without
charge, at least one conformed copy of each Registration Statement and any post-effective amendment thereto (without any documents incorporated therein by reference or exhibits thereto, unless requested); 
  

 -8- 

 (viii) in the case of a Shelf Registration, cooperate with the Holders of Registrable
Securities to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold and not bearing any restrictive legends and enable such Registrable Securities to be issued in such denominations and
registered in such names (consistent with the provisions of the Indenture) as such Holders may reasonably request a reasonable period of time prior to the closing of any sale of Registrable Securities; 
  
 (ix) in the case of a Shelf Registration, upon the
occurrence of any event contemplated by Section 3(a)(v)(5) hereof, use their reasonable best efforts to prepare and file with the SEC a supplement or post-effective amendment to such Shelf Registration Statement or the related Prospectus or any
document incorporated therein by reference or file any other required document so that, as thereafter delivered to purchasers of the Registrable Securities, such Prospectus will not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and the Company and the Guarantors shall notify the Holders of Registrable Securities to suspend use of the
Prospectus as promptly as practicable after the occurrence of such an event, and such Holders hereby agree to suspend use of the Prospectus until the Company and the Guarantors have amended or supplemented the Prospectus to correct such misstatement
or omission; 
  
 (x) a reasonable time prior to
the filing of any Registration Statement, any Prospectus, any amendment to a Registration Statement or amendment or supplement to a Prospectus, provide copies of such document to the Initial Purchasers and their counsel (and, in the case of a Shelf
Registration Statement, to the Holders of Registrable Securities and their counsel) and make such of the representatives of the Company and the Guarantors as shall be reasonably requested by the Initial Purchasers or their counsel (and, in the case
of a Shelf Registration Statement, the Holders of Registrable Securities included in such Shelf Registration or their counsel) available for discussion of such document; and the Company and the Guarantors shall not, at any time after initial filing
of a Registration Statement, file any Prospectus, any amendment of or supplement to a Registration Statement or a Prospectus of which the Initial Purchasers and their counsel (and, in the case of a Shelf Registration Statement, the Holders of
Registrable Securities and their counsel) shall not have previously been advised and furnished a copy or to which the Initial Purchasers or their counsel (and, in the case of a Shelf Registration Statement, the Holders of Registrable Securities or
their counsel) shall reasonably object within a reasonable period of time; 
  
 (xi) obtain a CUSIP number for all Exchange Securities or Registrable Securities, as the case may be, not later than the effective date of a Registration Statement; 
  
 (xii) cause the Indenture to be qualified under the Trust
Indenture Act in connection with the registration of the Exchange Securities or Registrable Securities, as the case may be; cooperate with the Trustee and the Holders to effect such changes to the Indenture as may be required for the Indenture to be
so qualified in accordance with the terms of the Trust Indenture Act; and execute, and use their reasonable best efforts to cause the Trustee to execute, all documents as may be required to effect such changes and all other forms and documents
required to be filed with the SEC to enable the Indenture to be so qualified in a timely manner; 
  
 (xiii) in the case of a Shelf Registration, make available for inspection by a representative of the Holders of the Registrable Securities
(an “Inspector”), any Underwriter participating in any disposition pursuant to such Shelf Registration Statement, one counsel (in addition to any local counsel) and one firm of accountants designated by the Holders of Registrable
Securities and one counsel (in addition to any local counsel) and one firm of accountants designated by such 

  

 -9- 

 
Underwriter, at reasonable times and in a reasonable manner, all pertinent financial and other records, documents and properties of the Company and the
Guarantors, and cause the respective officers, directors and employees of the Company and the Guarantors to supply all information reasonably requested by any such Inspector, Underwriter, attorney or accountant in connection with a Shelf
Registration Statement; in order to comply with their due diligence requirements, provided that if any such information is identified by the Company or any Guarantor as being confidential or proprietary, each Person receiving such information
shall agree to keep such information confidential for purposes of Regulation FD and take such actions as are reasonably necessary to protect the confidentiality of such information to the extent such action is otherwise not inconsistent with, an
impairment of or in derogation of the rights and interests of any Inspector, Holder or Underwriter); 
  
 (xiv) in the case of a Shelf Registration, use their reasonable best efforts to cause all Registrable Securities to be listed on any
securities exchange or any automated quotation system on which similar securities issued or guaranteed by the Company or any Guarantor are then listed if requested by the Majority Holders, to the extent such Registrable Securities satisfy applicable
listing requirements; 
  
 (xv) if reasonably
requested by any Holder of Registrable Securities covered by a Shelf Registration Statement, promptly include in a Prospectus supplement or post-effective amendment such information with respect to such Holder as such Holder reasonably requests to
be included therein and make all required filings of such Prospectus supplement or such post-effective amendment as soon as practicable after the Company has received notification of the matters to be so included in such filing; and 
  
 (xvi) in the case of a Shelf Registration, enter into such
customary agreements (including, if requested, an underwriting agreement in customary form including customary indemnification and contribution provisions) and take all such other actions in connection therewith (including those requested by the
Holders of a majority in principal amount of the Registrable Securities being sold) in order to expedite or facilitate the disposition of such Registrable Securities including, but not limited to, an Underwritten Offering and in such connection, (1)
to the extent possible, make such representations and warranties to any Underwriters of such Registrable Securities and to any Holder of Registrable Securities that has reasonably demonstrated to the Company that such Holder may have a “due
diligence” defense under Section 11 of the Securities Act with respect to the business of the Company and its subsidiaries and the Registration Statement, Prospectus and documents incorporated by reference or deemed incorporated by reference,
if any, in each case, in form, substance and scope as are customarily made by issuers to underwriters in underwritten offerings and confirm the same if and when requested, (2) obtain opinions of counsel to the Company and the Guarantors (which
counsel and opinions, in form, scope and substance, shall be reasonably satisfactory to the Holders of a majority in principal amount of the Registrable Securities being sold (to the extent such Holders have reasonably demonstrated to the Company
that such Holder may have a “due diligence” defense under Section 11 of the Securities Act) such Underwriters and their respective counsel) and addressed to each such selling Holder and Underwriter of Registrable Securities, covering the
matters customarily covered in opinions requested in underwritten offerings, (3) (i) obtain “comfort” letters from the independent certified public accountants of the Company and the Guarantors (and, if necessary, any other certified
public accountant of any subsidiary of the Company or any Guarantor, or of any business acquired by the Company or any Guarantor for which financial statements and financial data are or are required to be included in the Registration Statement)
addressed to each Underwriter of Registrable Securities, such letters to be in customary form and covering matters of the type customarily covered in “comfort” letters in connection with underwritten offerings and (ii) use their reasonable

  

 -10- 

 
best efforts to obtain “comfort” letters from the independent certified public accountants of the Company and the Guarantors (and, if necessary,
any other certified public accountant of any subsidiary of the Company or any Guarantor, or of any business acquired by the Company or any Guarantor for which financial statements and financial data are or are required to be included in the
Registration Statement) addressed to each selling Holder (to the extent such Holder has reasonably demonstrated to the Company and to the independent certified public accountants of the Company that such Holder may have a “due diligence”
defense under Section 11 of the Securities Act), such letters to be in customary form and covering matters of the type customarily covered in “comfort” letters in connection with underwritten offerings and (4) deliver such documents and
certificates as may be reasonably requested by the Holders of a majority in principal amount of the Registrable Securities being sold (to the extent such Holders have reasonably demonstrated to the Company that such Holder may have a “due
diligence” defense under Section 11 of the Securities Act) or the Underwriters, and which are customarily delivered in underwritten offerings, to evidence the continued validity of the representations and warranties of the Company and the
Guarantors made pursuant to clause (1) above and to evidence compliance with any customary conditions contained in an underwriting agreement. 
  
 (b) In the case of a Shelf Registration Statement, the Company may require each Holder of Registrable Securities to furnish to the Company such
information regarding such Holder and the proposed disposition by such Holder of such Registrable Securities as the Company and the Guarantors may from time to time reasonably request in writing, and the Company may exclude from such registration
the Registrable Securities of any Holder that fails to furnish such information within a reasonable time after receiving such request. 
  
 (c) In the case of a Shelf Registration Statement, each Holder of Registrable Securities agrees that, upon receipt of any notice from the Company and the
Guarantors of the happening of any event of the kind described in Section 3(a)(v)(3), 3(a)(v)(5) or 3(a)(v)(7) hereof, such Holder will forthwith discontinue disposition of Registrable Securities pursuant to the Shelf Registration Statement until
such Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 3(a)(ix) hereof or notice from the Company that dispositions of Registrable Securities pursuant to the Shelf Registration Statement may be
resumed and, if so directed by the Company and the Guarantors, such Holder will deliver to the Company and the Guarantors all copies in its possession, other than permanent file copies then in such Holder’s possession, of the Prospectus
covering such Registrable Securities that is current at the time of receipt of such notice. 
  
 (d) If the Company and the Guarantors shall give any notice pursuant to Section 3(c) hereof to suspend the disposition of Registrable Securities pursuant to a Shelf Registration Statement, the Company and the
Guarantors shall extend the period during which such Shelf Registration Statement shall be maintained effective pursuant to this Agreement by the number of days during the period from and including the date of the giving of such notice to and
including the date when the Holders of such Registrable Securities shall have received copies of the supplemented or amended Prospectus necessary to resume such dispositions or notice from the Company that dispositions of Registrable Securities
pursuant to the Shelf Registration Statement may be resumed. The Company and the Guarantors may give any such notice only twice during any 365-day period and any such suspensions shall not exceed 30 days for each suspension and there shall not be
more than two suspensions in effect during any 365-day period. 
  
 (e) The Holders of Registrable Securities covered by a Shelf Registration Statement who desire to do so may sell such Registrable Securities in an Underwritten Offering. In any such Underwritten Offering, the investment bank or investment
banks and manager or managers (each an “Underwriter”) that will administer the offering will be selected by the Holders of a majority in principal amount of the Registrable Securities included in such offering. 
  

 -11- 

 4. Participation of Broker-Dealers in Exchange Offer. 
  
 (a) The Staff has taken the position that any broker-dealer that receives
Exchange Securities for its own account in the Exchange Offer in exchange for Securities that were acquired by such broker-dealer as a result of market-making or other trading activities (a “Participating Broker-Dealer”) may be
deemed to be an “underwriter” within the meaning of the Securities Act and must deliver a prospectus meeting the requirements of the Securities Act in connection with any resale of such Exchange Securities. 
  
 The Company and the Guarantors understand that it is the Staff’s
position that if the Prospectus contained in the Exchange Offer Registration Statement includes a plan of distribution containing a statement to the above effect and the means by which Participating Broker-Dealers may resell the Exchange Securities,
without naming the Participating Broker-Dealers or specifying the amount of Exchange Securities owned by them, such Prospectus may be delivered by Participating Broker-Dealers to satisfy their prospectus delivery obligation under the Securities Act
in connection with resales of Exchange Securities for their own accounts, so long as the Prospectus otherwise meets the requirements of the Securities Act. 
  
 (b) In light of the above, and notwithstanding the other provisions of this Agreement, the Company and the Guarantors agree to amend or supplement the
Prospectus contained in the Exchange Offer Registration Statement for a period of up to 180 days after the last Exchange Date (as such period may be extended pursuant to Section 3(d) of this Agreement), if requested by the Initial Purchasers or by
one or more Participating Broker-Dealers, in order to expedite or facilitate the disposition of any Exchange Securities by Participating Broker-Dealers consistent with the positions of the Staff recited in Section 4(a) above. The Company and the
Guarantors further agree that Participating Broker-Dealers shall be authorized to deliver such Prospectus during such period in connection with the resales contemplated by this Section 4, subject to the right of the Company to suspend use of any
Prospectus pursuant to Section 3(c) hereof. 
  
 (c) The Initial
Purchasers shall have no liability to the Company, any Guarantor or any Holder with respect to any request that they may make pursuant to Section 4(b) above. 
  
 5. Indemnification and Contribution. 
  
 (a) The Company and each Guarantor, jointly and severally, agree to indemnify and hold harmless each Initial Purchaser and each Holder, their respective
affiliates, directors and officers and each Person, if any, who controls any Initial Purchaser or any Holder within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and all losses, claims,
damages and liabilities (including, without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that arise out of, or
are based upon, any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement or any Prospectus or any omission or alleged omission to state therein a material fact required to be stated therein or
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or
omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to any Initial Purchaser or information relating to any Holder furnished to the Company in writing through JPMorgan or any selling
Holder expressly for use therein, provided that with respect to any such untrue statement in or omission from any preliminary prospectus relating to a Registration Statement, the indemnity agreement contained in this paragraph (a) shall not
inure to the benefit of any Holder to the extent that the sale to the Person asserting any such loss, claim, damage or liability was an initial resale by such Holder and any such loss, claim, damage or liability of or with respect to such 

  

 -12- 

 
Holder results from the fact that both (i) a copy of the final Prospectus was not sent or given to such Person at or prior to the written confirmation or the
sale of such Securities to such Person and (ii) the untrue statement in or omission from such preliminary prospectus was corrected in the final Prospectus relating to such Registration Statement unless, in either case, such failure to deliver the
Prospectus was a result of non-compliance by the Company or any of the Guarantors with the provisions of Section 3 hereof. 
  
 (b) Each Holder agrees, severally and not jointly, to indemnify and hold harmless the Company, the Guarantors, the Initial Purchasers and the other
selling Holders, the directors and officers of the Company and the Guarantors, each officer of the Company and the Guarantors who signed the Registration Statement and each Person, if any, who controls the Company, any of the Guarantors, any Initial
Purchaser and any other selling Holder within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims,
damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Holder furnished to the Company in
writing by such Holder expressly for use in any Registration Statement and any Prospectus. 
  
 (c) If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any Person in respect of which indemnification may be sought pursuant
to either paragraph (a) or (b) above, such Person (the “Indemnified Person”) shall promptly notify the Person against whom such indemnification may be sought (the “Indemnifying Person”) in writing; provided
that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under this Section 5 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses)
by such failure; and provided, further, that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under this Section 5. If any such proceeding
shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall be entitled to participate therein and to the extent that it wishes, jointly with any other
similarly notified Indemnifying Person, to assume the defense thereof with counsel reasonably satisfactory to the Indemnified Person. After notice from the Indemnifying Person to the Indemnified Person of its election to assume the defense of such
claim or action, the Indemnifying Person shall not be liable to the Indemnified Person under this Section 5 for any legal or other expenses subsequently incurred by the Indemnified Person in connection with the defense thereof other than reasonable
costs of investigation; provided, however, that an Indemnified Person shall have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel for the Indemnified Person will be at the
expense of such Indemnified Person unless (i) the employment of counsel by the Indemnified Person has been authorized in writing by the Indemnifying Person, (ii) the Indemnified Person has reasonably concluded (based upon advice of counsel to the
Indemnified Person) that there may be legal defenses available to it or other Indemnified Persons that are different from or in addition to those available to the Indemnifying Person, (iii) a conflict or potential conflict exists (based upon advice
of counsel to the Indemnified Person) between the Indemnified Person and the Indemnifying Person (in which case the Indemnifying Person will not have the right to direct the defense of such action on behalf of the Indemnified Person) or (iv) the
Indemnifying Person has not in fact employed counsel reasonably satisfactory to the Indemnified Person to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases the
reasonable fees, disbursements and other charges of counsel will be at the expense of the Indemnifying Person. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same
jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be reimbursed as they are incurred. Any such separate firm (x)
for any Initial Purchaser, its affiliates, directors and officers and any control Persons of such Initial Purchaser shall be designated in writing by JPMorgan, (y) for any Holder, its directors 

  

 -13- 

 
and officers and any control Persons of such Holder shall be designated in writing by the Majority Holders and (z) in all other cases shall be designated in
writing by the Company. Each Indemnified Person, as a condition to the agreements contained in this Section 5, shall use all reasonable efforts to cooperate with the Indemnifying Person in the defense of any such action or claim. The Indemnifying
Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified
Person from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person
for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after
receipt by the Indemnifying Person of such request and (ii) the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the
written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such
Indemnified Person, unless such settlement (A) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such
proceeding and (B) does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. 
  
 (d) If the indemnification provided for in paragraphs (a) and (b) above is unavailable to an Indemnified Person or insufficient in respect of any losses,
claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result
of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company and the Guarantors from the offering of the Securities and the Exchange Securities, on the one hand, and
by the Holders from receiving Securities or Exchange Securities registered under the Securities Act, on the other hand, or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to
reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company and the Guarantors on the one hand and the Holders on the other in connection with the statements or omissions that resulted in such losses,
claims, damages or liabilities, as well as any other relevant equitable considerations. The relative fault of the Company and the Guarantors on the one hand and the Holders on the other shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company and the Guarantors or by the Holders and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission. 
  
 (e) The Company, the Guarantors and the Holders agree that it would not be just and equitable if contribution pursuant to this Section 5 were determined
by pro rata allocation (even if the Holders were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in paragraph (d) above. The amount
paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by
such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of this Section 5, in no event shall a Holder be required to contribute any amount in excess of the amount by which the total price at which the
Securities or Exchange Securities sold by such Holder exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No Person guilty of
fraudulent 

  

 -14- 

 
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such
fraudulent misrepresentation. 
  
 (f) The remedies provided for in
this Section 5 are not exclusive and shall not limit any rights or remedies that may otherwise be available to any Indemnified Person at law or in equity. 
  
 (g) The indemnity and contribution provisions contained in this Section 5 shall remain operative and in full force and effect regardless of (i) any
termination of this Agreement, (ii) any investigation made by or on behalf of the Initial Purchasers or any Holder or any Person controlling any Initial Purchaser or any Holder, or by or on behalf of the Company or the Guarantors or the officers or
directors of or any Person controlling the Company or the Guarantors, (iii) acceptance of any of the Exchange Securities and (iv) any sale of Registrable Securities pursuant to a Shelf Registration Statement. 
  
 6. General. 
  
 (a) No Inconsistent Agreements. The Company and the Guarantors
represent, warrant and agree that (i) the rights granted to the Holders hereunder do not in any way conflict with and are not inconsistent with the rights granted to the holders of any other outstanding securities issued or guaranteed by the Company
or any Guarantor under any other agreement and (ii) neither the Company nor any Guarantor has entered into, or on or after the date of this Agreement will enter into, any agreement that is inconsistent with the rights granted to the Holders of
Registrable Securities in this Agreement or otherwise conflicts with the provisions hereof. 
  
 (b) Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions
hereof may not be given unless the Company and the Guarantors have obtained the written consent of Holders of at least a majority in aggregate principal amount of the outstanding Registrable Securities affected by such amendment, modification,
supplement, waiver or consent; provided that no amendment, modification, supplement, waiver or consent to any departure from the provisions of Section 6 hereof shall be effective as against any Holder of Registrable Securities unless
consented to in writing by such Holder. Any amendments, modifications, supplements, waivers or consents pursuant to this Section 6(b) shall be by a writing executed by each of the parties hereto. 
  
 (c) Notices. All notices and other communications provided for or
permitted hereunder shall be made in writing by hand-delivery, registered first-class mail, telex, telecopier, or any courier guaranteeing overnight delivery (i) if to a Holder, at the most current address given by such Holder to the Company by
means of a notice given in accordance with the provisions of this Section 6(c), which address initially is, with respect to the Initial Purchasers, the address set forth in the Purchase Agreement; (ii) if to the Company and the Guarantors, initially
at the Company’s address set forth in the Purchase Agreement and thereafter at such other address, notice of which is given in accordance with the provisions of this Section 6(c) and (iii) to such other persons at their respective addresses as
provided in the Purchase Agreement and thereafter at such other address, notice of which is given in accordance with the provisions of this Section 6(c). All such notices and communications shall be deemed to have been duly given: at the time
delivered by hand, if personally delivered; five Business Days after being deposited in the mail, postage prepaid, if mailed; when answered back, if telexed; when receipt is acknowledged, if telecopied; and on the next Business Day if timely
delivered to an air courier guaranteeing overnight delivery. 
  
 (d) Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors, assigns and transferees of each of the parties, including, without limitation and without the need for an express
assignment, subsequent Holders; provided that nothing herein shall be deemed to 

  

 -15- 

 
permit any assignment, transfer or other disposition of Registrable Securities in violation of the terms of the Purchase Agreement or the Indenture. If any
transferee of any Holder shall acquire Registrable Securities in any manner, whether by operation of law or otherwise, such Registrable Securities shall be held subject to all the terms of this Agreement, and by taking and holding such Registrable
Securities such Person shall be conclusively deemed to have agreed to be bound by and to perform all of the terms and provisions of this Agreement and such Person shall be entitled to receive the benefits hereof. The Initial Purchasers (in their
capacity as Initial Purchasers) shall have no liability or obligation to the Company or the Guarantors with respect to any failure by a Holder to comply with, or any breach by any Holder of, any of the obligations of such Holder under this
Agreement. 
  
 (e) Third Party Beneficiaries. Each Holder
shall be a third party beneficiary to the agreements made hereunder (excluding those agreements made in Section 5 hereto) between the Company and the Guarantors, on the one hand, and the Initial Purchasers, on the other hand, and shall have the
right to enforce such agreements directly to the extent it deems such enforcement necessary or advisable to protect its rights or the rights of other Holders hereunder. 
  
 (f) Counterparts. This Agreement may be executed in any number of counterparts and by the parties hereto in separate
counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 
  
 (g) Headings. The headings in this Agreement are for convenience of reference only, are not a part of this Agreement and shall not limit or
otherwise affect the meaning hereof. 
  
 (h) Governing Law.
This Agreement shall be governed by and construed in accordance with the laws of the State of New York. 
  
 (i) Miscellaneous. This Agreement contains the entire agreement between the parties relating to the subject matter hereof and supersedes all oral
statements and prior writings with respect thereto. If any term, provision, covenant or restriction contained in this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable or against public policy, the remainder
of the terms, provisions, covenants and restrictions contained herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated. The Company, the Guarantors and the Initial Purchasers shall endeavor in good faith
negotiations to replace the invalid, void or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, void or unenforceable provisions. 
  
 (j) Addition and Removal of Guarantors. In the event that any Person
that is not a party to this Agreement shall at any time guarantee any Registrable Securities or Exchange Securities then, prior to or contemporaneously with such Person entering into its guarantee of the Registrable Securities or the Exchange
Securities, as the case may be, such Person, the other Guarantors and the Company shall enter into an amendment to this Agreement (which amendment need not be signed by the Initial Purchasers), pursuant to which such Person shall become a Guarantor
under this Agreement with all the duties and obligations of a Guarantor hereunder. If a Guarantor is released from all of its Guarantees of the Registrable Securities and the Exchange Securities, such Guarantor shall be automatically and
unconditionally released and discharged from all of its obligations under this Agreement (other than (i) obligations and liabilities which may have arisen prior to the time of such release and discharge and (ii) any obligation set forth in Section 5
hereof to the extent such obligation arises out of any untrue statement or alleged untrue statement or omission or alleged omission or suit, action or proceeding which occurred prior to such release) without any further action required on the part
of the Company, the Guarantors or any other Person. 
  

 -16- 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

					
	 DAVITA INC.

		
	By:	 	/s/    JOSEPH
SCHOHL        
	 	 	 Name:
	 	Joseph Schohl
	 	 	 Title:
	 	Vice President, Secretary and General Counsel

  

 -17- 

  
 GUARANTORS 
  

			
	 	  	 Astro, Hobby, West Mt. Renal Care Limited Partnership
 Bay Area Dialysis Partnership
 Beverly Hills Dialysis Partnership
 Carroll County Dialysis Facility, Inc.
 Continental Dialysis Center of Springfield-Fairfax, Inc.
 Continental Dialysis Centers, Inc.
 DaVita Nephrology Associates of Utah,
L.L.C.
 DaVita – West, LLC
 Dialysis Specialists of Dallas,
Inc.
 Downriver Centers, Inc.
 East End Dialysis Center,
Inc.
 Eastmont Dialysis Partnership
 Elberton Dialysis Facility,
Inc.
 Flamingo Park Kidney Center, Inc.
 Houston Kidney
Center/Total Renal Care Integrated Service Network Limited Partnership
 Kidney Care Rx, Inc. (fka Total Renal Support Services, Inc.)
 Kidney Care Services, LLC
 Lincoln Park Dialysis Services, Inc.
 Mason-Dixon Dialysis Facilities, Inc.
 Nephrology Medical Associates of
Georgia, LLC
 Open Access Sonography, Inc.
 Orange Dialysis,
LLC
 Pacific Coast Dialysis Center
 PDI Holdings, Inc.

PDI Supply, Inc.
 Peninsula Dialysis Center, Inc.
 Physicians Dialysis Acquisitions, Inc.
 Physicians Dialysis Ventures,
Inc.
 Physicians Dialysis, Inc.
 Renal Treatment Centers –
California, Inc.
 Renal Treatment Centers – Hawaii, Inc.
 Renal Treatment Centers – Illinois, Inc.
 Renal Treatment Centers – Mid-Atlantic, Inc.
 Renal Treatment Centers – Northeast, Inc.
 Renal Treatment Centers –
Southeast, LP
 Renal Treatment Centers – West, Inc.
 Renal
Treatment Centers, Inc.
 RMS DM, LLC
 RTC - Texas Acquisition,
Inc.
 RTC Holdings, Inc.
 RTC TN, Inc.
 Sierra Rose Dialysis Center, LLC
 Southwest Atlanta Dialysis Centers,
LLC
 Total Acute Kidney Care, Inc.
 Total Renal Care / Eaton
Canyon Dialysis Center Partnership
 Total Renal Care of Colorado, Inc.
 Total Renal Care of Utah, L.L.C.
 Total Renal Care Texas Limited Partnership

  

 -18- 

			
	 	  	 Total Renal Care, Inc.
 Total Renal Care/Peralta Renal
Center Partnership
 Total Renal Care/Piedmont Dialysis Partnership
 Total Renal Laboratories, Inc.
 Total Renal Research, Inc.
 TRC – Indiana, LLC
 TRC of New York, Inc.
 TRC
West, Inc.
 Tri-City Dialysis Center, Inc.

  

			
		
	By:	 	/s/    H.W. GUY SEAY        
	 	 	H.W. Guy Seay, Authorized Signatory

  

 -19- 

 Confirmed and accepted as of the date first above written: 
  

			
	 J.P. MORGAN SECURITIES INC.

	
	For itself and on behalf of the several Initial Purchasers
		
	By:	 	/s/    ANDREW T. BRODE        
	 	 	Authorized Signatory

  

 -20- 

  
 SCHEDULE 1 
  
 Guarantors 
  

			
	 Name

	 	 Jurisdiction

	 1.      Astro, Hobby, West Mt. Renal Care Limited Partnership
	 	Delaware
	 2.      Bay Area Dialysis Partnership
	 	Florida
	 3.      Beverly Hills Dialysis Partnership
	 	California
	 4.      Carroll County Dialysis Facility, Inc.
	 	Maryland
	 5.      Continental Dialysis Center of Springfield-Fairfax, Inc.
	 	Virginia
	 6.      Continental Dialysis Centers, Inc.
	 	Virginia
	 7.      DaVita Nephrology Associates of Utah, L.L.C.
	 	Utah
	 8.      DaVita – West, LLC
	 	Delaware
	 9.      Dialysis Specialists of Dallas, Inc.
	 	Texas
	 10.    Downriver Centers, Inc.
	 	Delaware
	 11.    East End Dialysis Center, Inc.
	 	Virginia
	 12.    Eastmont Dialysis Partnership
	 	California
	 13.    Elberton Dialysis Facility, Inc.
	 	Georgia
	 14.    Flamingo Park Kidney Center, Inc.
	 	Florida
	 15.    Houston Kidney Center/Total Renal Care Integrated Service Network Limited Partnership
	 	Delaware
	 16.    Kidney Care Rx, Inc. (fka Total Renal Support Services, Inc.)
	 	Delaware
	 17.    Kidney Care Services, LLC
	 	Delaware
	 18.    Lincoln Park Dialysis Services, Inc.
	 	Illinois
	 19.    Mason-Dixon Dialysis Facilities, Inc.
	 	Maryland
	 20.    Nephrology Medical Associates of Georgia, LLC
	 	Georgia
	 21.    Open Access Sonography, Inc.
	 	Florida
	 22.    Orange Dialysis, LLC
	 	California
	 23.    Pacific Coast Dialysis Center
	 	California
	 24.    PDI Holdings, Inc.
	 	Delaware
	 25.    PDI Supply, Inc.
	 	Delaware
	 26.    Peninsula Dialysis Center, Inc.
	 	Virginia
	 27.    Physicians Dialysis Acquisitions, Inc.
	 	Delaware
	 28.    Physicians Dialysis Ventures, Inc.
	 	Delaware
	 29.    Physicians Dialysis, Inc.
	 	Delaware
	 30.    Renal Treatment Centers – California, Inc.
	 	Delaware
	 31.    Renal Treatment Centers – Hawaii, Inc.
	 	Delaware
	 32.    Renal Treatment Centers – Illinois, Inc.
	 	Delaware
	 33.    Renal Treatment Centers – Mid-Atlantic, Inc.
	 	Delaware
	 34.    Renal Treatment Centers – Northeast, Inc.
	 	Delaware
	 35.    Renal Treatment Centers – Southeast, LP
	 	Delaware
	 36.    Renal Treatment Centers – West, Inc.
	 	Delaware
	 37.    Renal Treatment Centers, Inc.
	 	Delaware
	 38.    RMS DM, LLC
	 	Delaware
	 39.    RTC - Texas Acquisition, Inc.
	 	Texas
	 40.    RTC Holdings, Inc.
	 	Delaware
	 41.    RTC TN, Inc.
	 	Delaware

  

			
	 42.    Sierra Rose Dialysis Center, LLC
	 	Delaware
	 43.    Southwest Atlanta Dialysis Centers, LLC
	 	Delaware
	 44.    Total Acute Kidney Care, Inc.
	 	Florida
	 45.    Total Renal Care / Eaton Canyon Dialysis Center Partnership
	 	California
	 46.    Total Renal Care of Colorado, Inc.
	 	Colorado
	 47.    Total Renal Care of Utah, L.L.C.
	 	Delaware
	 48.    Total Renal Care Texas Limited Partnership
	 	Delaware
	 49.    Total Renal Care, Inc.
	 	California
	 50.    Total Renal Care/Peralta Renal Center Partnership
	 	California
	 51.    Total Renal Care/Piedmont Dialysis Partnership
	 	California
	 52.    Total Renal Laboratories, Inc.
	 	Florida
	 53.    Total Renal Research, Inc.
	 	Delaware
	 54.    TRC – Indiana, LLC
	 	Indiana
	 55.    TRC of New York, Inc.
	 	New York
	 56.    TRC West, Inc.
	 	Delaware
	 57.    Tri-City Dialysis Center, Inc.
	 	VirginiaPrime Warehouse Supplier Agreement

 Exhibit 10.1 
  
 [CONFIDENTIAL TREATMENT HAS BEEN REQUESTED BY DRUGMAX, INC. 
 CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND 
 HAVE BEEN SEPARATELY
FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.] 
  
 PRIME
WAREHOUSE SUPPLIER 
 AGREEMENT 
  
 This Agreement is made as of the 28th day of December, 2004, is by and between Familymeds, Inc., a Connecticut corporation, and Valley Drug Company South,
a Louisiana corporation hereinafter collectively known as “Customer” and D&K Healthcare Resources, Inc. hereinafter known as “D&K”. 
  

	 	1.	Prime Warehouse Supplier. Subject to the terms and conditions hereof, D&K shall be the primary supplier of Products to Customer and Customer shall purchase Products
primarily from D&K for all of Customer’s present and future locations, including, without limitation, the locations listed on Schedule A. As used herein, the term “Products” means prescription drugs, OTC, and other merchandise
generally available from D&K. As used herein the terms “primary” and “primarily” when applied with respect to Customer means that Customer shall purchase from D & K (i) a minimum of ****************** each year calculated
on a rolling twelve month basis of non-Customer warehoused Products from the stores described on Schedule A and (ii) at least *****% of its Products through D & K’s ***** generic program during every calendar quarter during the term hereof.
D&K shall endeavor to supply all Products ordered by Customer hereunder. 

  

	 	2.	Stocking Requests. D&K agrees to stock all routinely ordered source contract items for the Locations. D&K will respond to all stocking requests on a timely basis.
Upon receipt of a written request from Customer that includes NDC number, monthly usage, and an order to cover the first shipment, D&K will immediately initiate the stocking and ordering process. Products are usually in stock and available for
shipment within one to three weeks of the original request date. 

  

	 	3.	Contract Administration. To accelerate the contract loading and manufacturer confirmation process, Customer shall provide D&K with the following contract information: NDC
number, product description, negotiated price, effective dates, and vendor contract or reference number. 

  

	 	4.	Chargeback Denials by Manufacturers. D&K will make reasonable efforts to accurately maintain contract pricing agreements in its system including confirming both pricing
and customer eligibility. If manufacturers deny chargeback claims to D&K, Customer shall upon receipt of invoice from D&K, pay to D&K the amount of the denied chargeback. Prior to such invoicing, D&K will make reasonable efforts to
recover the denied chargeback from the manufacturer and D&K shall provide notice no later than the end of each calendar quarter to Customer of such denials. 

	 	5.	Orders and Deliveries. Orders may be placed weekdays until 6:00 P.M. local time for next business day delivery before 12:00 PM. Telephone and fax orders may be placed with
the Customer Service Department weekdays until 5:00 P.M. local time for next business day delivery. Orders will be delivered in a sealed, returnable plastic tote individually labeled by store to the Customer’s warehouse facility. A signature
may be required by the individual accepting the shipment to verify the number of cartons received. 

  

	 	6.	Freight Terms. Freight will be F.O.B. destination ***** on all regularly scheduled deliveries to Customer. D&K agrees to waive all daily minimum order requirements to
qualify for prepaid freight. For special requests such as airfreight, express courier service, or bus shipments, D&K will ship prepaid and bill the freight charges on a separate invoice. 

  

	 	7.	Prime Warehouse supplier Services. D&K shall provide the following services to Customer. 

  

	 	A.	Customer Service Department: D&K’s customer service department is professionally staffed from 8:00 A.M. to 6:00 P.M. excluding weekends and holidays.

  

	 	B.	Emergency Orders: D&K provides 24 hour, 7 day-a-week emergency delivery service in life-threatening situations. Customer will be provided with emergency telephone and pager
numbers. 

  

	 	C.	Drop-Ship Service: D&K shall provide drop-ship service to Customer upon request. Manufacturers will typically call for authorization to bill through D&K and approval will be
promptly given. Manufacturer drop-ship invoices will be promptly processed by D&K within two business days of receipt. 

  

	 	D.	Price Stickers: D&K offers multiple encoded price sticker formats for both Rx and OTC products. Information provided on the sticker is AWP, net landed price, quantity purchased,
date purchased and the D&K item number. 

  

	 	E.	Shelf Labels. D&K will provide scannable shelf labels upon request. 

  

	 	F.	Material Safety Data Sheets: D&K will provide Material Safety Data Sheets (MSDS) upon request. 

  

	 	8.	Pricing and Payment Terms. The purchase prices and payment terms for Products supplied hereunder are set forth in the attached Schedule B. All prices quoted in this Agreement
and all other obligations of D&K described herein are based on the agreement that Customer has designated, and will utilize, D&K as its Primary Warehouse supplier. 

  

 2 

	 	9.	Definitions of Cost. For this Agreement, the following definitions of costs will apply: 

  
 Individual Contracts: For Products purchased under a Customer negotiated contract, cost is defined to be ***********.

  
 Net-Priced Items: *************. 
  
 Other Items: For the purpose of this Agreement, items not covered under
buying group, individual contracts, or net-priced, cost is defined to be ********. 
  

	 	10.	Credits. Credit for returned goods will be processed within five days of receipt of the merchandise. Credit for billing errors or mispicks is processed immediately. A copy of
the credit memo will be sent with Customer’s next order. Returns authorization requests may be transmitted electronically via Telxon at the Customer’s convenience. 

  

	 	11.	Return Goods Policy. D&K’s Return Goods Policy is attached hereto as Schedule C. D&K reserves the right to change such policy upon 30 days prior writeen notice
to Customer. 

  

	 	12.	Medicare/Medicaid. Customer acknowledges that any discounts, rebates, or other payments to it hereunder on items reimbursable by Medicare or a state healthcare program such
as Medicaid, may be reportable under applicable law by Customer to federal or state healthcare authorities respectively. Customer shall comply with all obligations to properly disclose and appropriately reflect discounts, rebates, and other payments
in accordance with any applicable law and shall also comply with Section 1128(B) (b) of the Social Security Act and applicable regulations. 

  

	 	13.	Warranty. D&K makes no representation or warranty of merchantability, fitness for a particular purpose, or otherwise, expressed or implied, with respect to any products;
and Customer acknowledges and agrees that any representations or warranties that relate to any products are made only by the manufacturer of such products. Customer acknowledges and agrees that its sole recourse for the breach of any such
manufacturer’s representation and warranty is against the manufacturer. 

  

	 	14.	No Liability. Notwithstanding anything in this Agreement to the contrary, D&K shall have no liability for any special incidental, indirect or consequential damages,
including, without limitation, loss of opportunity, revenue or profit, in connection with or arising out of this Agreement or D&K’s performance hereunder, even if such damages were foreseeable. 

  

	 	15.	Extension of Credit. D&K shall extend credit in an amount determined by D&K in its reasonable discretion subject to Customer furnishing evidence of financial
responsibility, posting of security, and execution of a security agreement and other documents as D&K may require from time to time. Notwithstanding the foregoing, if at anytime, or from time to time, D&K believes that Customer’s
ability to make payments hereunder is impaired 

  

 3 

 or Customer’s financial condition has materially deteriorated, D&K may require additional
security and may withhold deliveries until such security is received and may amend the payment terms hereunder. Customer agrees to abide by D&K’s standard credit terms and conditions. D&K shall provide advance notice to Customer of any
change in its requirements as far in advance as commercially reasonable. 
  

	 	16.	Term and Termination. 

  

	 	16.1	The term of this Agreement will be for a period of two years, commencing as of the date first set forth above. This Agreement shall renew automatically thereafter for successive one
year terms unless written non-renewal notice is provided by either party 30 days prior to the end of the initial term or any renewal term. 

  

	 	16.2	Notwithstanding the provisions of Section 16.1 hereof, either party may terminate this Agreement if the other party is in material breach of any of its obligations hereunder and
fails to cure such breach within 90 days (15 days for failure to make payments when due) after receipt of notice of such breach; and D&K may terminate this Agreement at any time if Customer or its assets (whether voluntarily or involuntarily)
become the subject of any bankruptcy or insolvency proceeding or if Customer makes an assignment for the benefit of its creditors. 

  

	 	16.3	If this Agreement is terminated by Customer pursuant to Section 16.2 hereof, Customer shall have no right to recover damages (whether characterized as consequential damages,
punitive damages or otherwise) other than its actual damages. 

  

	 	17.	Delays. Notwithstanding any provision of this Agreement to the contrary, each party’s obligations under this Agreement (other than Customer’s payment obligations)
will be excused if and to the extent that any delay or failure to perform such obligation is due to acts of nature, governmental actions, strikes or labor disputes or other causes or situations beyond the reasonable control of that party.

  

	 	18.	Confidentiality. Each party agrees to maintain in confidence the terms and conditions herein, and disclose the contents of this agreement only to those of its employees who
have a reasonable need to know of such information, except as otherwise agreed by the other party or as required by law. 

  

	 	19.	Taxes. Customer will pay, when due, any sales, use, excise, gross receipts or other federal, state or local taxes or other assessments (other than any tax based solely on the
net income of D&K) and related interest and penalties that D&K is at any time obligated to pay or collect in connection with or arising out of the transactions, contemplated by this Agreement. If D&K pays any such amounts, which Customer
is obligated to pay under this section, then Customer will promptly reimburse D&K in an amount equal to the amount so paid by D&K. 

  

 4 

	 	20.	Insurance. D&K will at all times during the term of this Agreement maintain product liability insurance at levels not less than $2 million, and will provide Customer with
a certificate confirming such insurance coverage promptly following request for same. Such policies will include Customer as an additional named insured. 

  

	 	21.	Severability. The unenforceability or invalidity of any term or provision herein, or of any portion thereof, will not affect the validity of enforceability of any other term
or provision, or portion thereof, herein contained. 

  

	 	22.	Assignment. Customer may not assign its interest in, or delegate its performance of its obligations under, this Agreement to any other person or party without D&K’s
prior written consent except to a wholly owned subsidiary, parent or affiliate company, or in the event of a merger of Customer, but in any event the assignee must have comparable ability to pay and financial condition. D&K may delegate its
performance and assign this Agreement in whole or in part except that Customer must consent to any assignment to ***************, which consent shall not be unreasonably withheld. 

  

	 	23.	Governing Law. This Agreement shall be construed and enforced under the law of the State of Delaware without regard to its conflict of laws principles.

  

	 	24.	Notices. All notices under this Agreement shall be in writing and shall be deemed duly given on the date received, if personally delivered, sent by facsimile transmission, or
by overnight courier, and addresses to the parties at the following addresses: 

  

			
	If to Customer to:	  	If to D&K to:
		
	Familymeds, Inc.	  	D&K Healthcare Resources, Inc.
	312 Farmington Avenue	  	8235 Forsyth Boulevard
	Farmington, CT 06032	  	St. Louis, MO. 63105
		
	FAX: (860) 676-2677	  	FAX: (314) 727-1943
		
	 Attention: Ed Mercadante
President and CEO
	  	 Attention: Vice President and
General Counsel

  

	 	25.	Headings. The headings of this Agreement are used only as a matter of convenience, and in no way define limit, construe or describe the scope or intent of any section of this
Agreement. 

  

	 	26.	Entire Agreement/Modification. This Agreement together with all Exhibits and attachments, as executed and accepted by the parties hereto, constitutes the entire understanding
and agreement of the parties relating to the subject matter hereof, and all prior or contemporaneous negotiations between the parties with respect to the subject matter hereof are hereby deemed merged into and replaced by this Agreement. The terms
hereof may not be waived, modified or amended in any way by conduct, custom or course of dealing, but solely by an instrument in writing duly signed by the party to be charged therewith. 

  

 5 

 In Witness whereof, the parties have caused this Agreement to be executed by their
authorized representatives on the day and year first written above. 
  

							
	D&K Healthcare Resources, Inc.	  	Familymeds, Inc.
				
	By:	 	  

	  	By:	 	  

	Name:	 	  

	  	Name:	 	Edgardo A. Mercadante
	Its:	 	  

	  	Its:	 	President & Chief Executive Officer
			
	 	 	 	  	Valley Drug Company South
				
	 	 	 	  	By:	 	  

	 	 	 	  	Name:	 	Edgardo A. Mercadante
	 	 	 	  	Its:	 	President & Chief Executive Officer

  

 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}]]